A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma

Aneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, Gajanan Sathe, Vinuth N. Puttamallesh, Ankit P. Jain, Sneha M. Pinto, Sai A. Balaji, Sandip Chavan, Nandini A. Sahasrabuddhe, Premendu P. Mathur, Mahesh M. Kumar, T. S.Keshava Prasad, Vani Santosh, Geethanjali Sukumar, Joseph A. Califano, Annapoorni Rangarajan, David Sidransky, Akhilesh Pandey, Harsha GowdaAditi Chatterjee

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Despite advances in clinical management, 5-year survival rate in patients with late-stage head and neck squamous cell carcinoma (HNSCC) has not improved significantly over the past decade. Targeted therapies have emerged as one of the most promising approaches to treat several malignancies. Though tyrosine phosphorylation accounts for a minority of total phosphorylation, it is critical for activation of signaling pathways and plays a significant role in driving cancers. To identify activated tyrosine kinase signaling pathways in HNSCC, we compared the phosphotyrosine profiles of a panel of HNSCC cell lines to a normal oral keratinocyte cell line. Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) was one of the kinases hyperphosphorylated at Tyr-321 in all HNSCC cell lines. Inhibition of DYRK1A resulted in an increased apoptosis and decrease in invasion and colony formation ability of HNSCC cell lines. Further, administration of the small molecular inhibitor against DYRK1A in mice bearing HNSCC xenograft tumors induced regression of tumor growth. Immunohistochemical labeling of DYRK1A in primary tumor tissues using tissue microarrays revealed strong to moderate staining of DYRK1A in 97.5% (39/40) of HNSCC tissues analyzed. Taken together our results suggest that DYRK1A could be a novel therapeutic target in HNSCC.

Original languageEnglish (US)
Article number36132
JournalScientific reports
Volume6
DOIs
StatePublished - Oct 31 2016

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this